Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Apr;48(4):351–357. doi: 10.1136/jcp.48.4.351

Histological diagnosis of cytomegalovirus hepatitis in liver allografts.

F Colina 1, N T Jucá 1, E Moreno 1, C Ballestín 1, J Fariña 1, M Nevado 1, C Lumbreras 1, R Gómez-Sanz 1
PMCID: PMC502555  PMID: 7615856

Abstract

AIMS--To determine the incidence of histologically documented cytomegalovirus (CMV) hepatitis following orthotopic liver transplantation (OLT) and to assess the effectiveness of immunohistochemistry and in situ hybridisation (ISH) in detecting CMV. To describe the histological pattern most frequently associated with CMV hepatitis in order to select the biopsy group in which these modern techniques are most effective. METHODS--A prospective histological study was carried out on 853 biopsy specimens, obtained from 191 liver allografts (160 patients). Specimens were stained with haematoxylin and eosin and immunohistochemically (avidin-biotin complex) using monoclonal antibodies directed against early and late CMV antigens. A retrospective selection was made of 23 specimens with viral inclusion bodies in cytomegalic cells (group A) to characterise the most frequently associated histological pattern, and of 34 other specimens without viral inclusion bodies (group B) but with the same microscopic features as group A. Re-cuts from both specimen groups were studied using immunohistochemistry and ISH with a CMV specific complementary DNA probe. RESULTS--CMV infection was confirmed in 35 specimens (29 by immunohistochemistry, 23 by presence of inclusion bodies in haematoxylin and eosin stained sections, 16 by ISH) from 27 patients (incidence 16.9%). CMV hepatitis was diagnosed within 46 +/- 19 (range 21-114) days posttransplant. Twenty on (91.3%) of the 23 biopsy specimens with inclusion bodies (group A) displayed heterogeneous inflammatory foci disseminated throughout the hepatic lobule. Nineteen specimens (82.6%) were positive by immunohistochemistry and 14 (60.9%) by ISH. In eight (23.5%) of the 34 group B specimens CMV infection was confirmed by immunohistochemistry (n = 6) or ISH (n = 2). Another 12 (35.3%) of the group B specimens negative on staining with haematoxylin and eosin, immunohistochemistry and ISH came from allografts in which previous or subsequent biopsy specimens were CMV positive. CONCLUSIONS--Demonstration of cytomegalic inclusion bodies in haematoxylin and eosin sections is sufficient for a diagnosis of CMV hepatitis. The routine use of immunohistochemistry in all allograft biopsy specimens in more sensitive than demonstration of inclusion bodies by staining with haematoxylin and eosin but may yield false negative results because of the focal distribution of positive cells. ISH was less sensitive than staining with haematoxylin and eosin and/or immunohistochemistry. A histological picture of "disseminated focal hepatitis" without viral inclusion bodies selects a group of allograft biopsy specimens in which immunohistochemistry and/or ISH may improve detection of CMV.

Full text

PDF
351

Images in this article

352Image
on p.352
353Image
on p.353
355Image
on p.355
356Image
on p.356
357Image
on p.357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonkowsky H. L., Lee R. V., Klatskin G. Acute granulomatous hepatitis. Occurrence in cytomegalovirus mononucleosis. JAMA. 1975 Sep 22;233(12):1284–1288. [PubMed] [Google Scholar]
  2. Bronsther O., Makowka L., Jaffe R., Demetris A. J., Breinig M. K., Ho M., Esquivel C. O., Gordon R. D., Iwatsuki S., Tzakis A. Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol. 1988 Apr;24(4):423–434. doi: 10.1002/jmv.1890240409. [DOI] [PubMed] [Google Scholar]
  3. Colina F. The role of histopathology in hepatic transplantation. Semin Diagn Pathol. 1992 Aug;9(3):200–209. [PubMed] [Google Scholar]
  4. Delgado R., Lumbreras C., Alba C., Pedraza M. A., Otero J. R., Gómez R., Moreno E., Noriega A. R., Payá C. V. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol. 1992 Jul;30(7):1876–1878. doi: 10.1128/jcm.30.7.1876-1878.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Espy M. J., Paya C. V., Holley K. E., Ludwig J., Hermans P. F., Wiesner R. H., Krom R. A., Smith T. F. Diagnosis of cytomegalovirus hepatitis by histopathology and in situ hybridization in liver transplantation. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):293–296. doi: 10.1016/0732-8893(91)90019-c. [DOI] [PubMed] [Google Scholar]
  6. Ho M. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Transplant Proc. 1991 Apr;23(2 Suppl 1):2–7. [PubMed] [Google Scholar]
  7. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  8. Johnson S. C., Stamm C. P., Hicks C. B. Tuberculous psoas muscle abscess following chemoprophylaxis with isoniazid in a patient with human immunodeficiency virus infection. Rev Infect Dis. 1990 Sep-Oct;12(5):754–756. doi: 10.1093/clinids/12.5.754. [DOI] [PubMed] [Google Scholar]
  9. Koment R. W. Restriction to human cytomegalovirus replication in vitro removed by physiological levels of cortisol. J Med Virol. 1989 Jan;27(1):44–47. doi: 10.1002/jmv.1890270110. [DOI] [PubMed] [Google Scholar]
  10. Lafemina R. L., Hayward G. S. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol. 1988 Feb;69(Pt 2):355–374. doi: 10.1099/0022-1317-69-2-355. [DOI] [PubMed] [Google Scholar]
  11. Masih A. S., Linder J., Shaw B. W., Jr, Wood R. P., Donovan J. P., White R., Markin R. S. Rapid identification of cytomegalovirus in liver allograft biopsies by in situ hybridization. Am J Surg Pathol. 1988 May;12(5):362–367. doi: 10.1097/00000478-198805000-00004. [DOI] [PubMed] [Google Scholar]
  12. Naoumov N. V., Alexander G. J., O'Grady J. G., Sutherland S., Aldis P., Portmann B. C., Williams R. Rapid diagnosis of cytomegalovirus infection by in-situ hybridisation in liver grafts. Lancet. 1988 Jun 18;1(8599):1361–1364. doi: 10.1016/s0140-6736(88)92180-0. [DOI] [PubMed] [Google Scholar]
  13. Niedobitek G., Finn T., Herbst H., Gerdes J., Grillner L., Landqvist M., Wirgart B. Z., Stein H. Detection of cytomegalovirus by in situ hybridisation and immunohistochemistry using new monoclonal antibody CCH2: a comparison of methods. J Clin Pathol. 1988 Sep;41(9):1005–1009. doi: 10.1136/jcp.41.9.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Paya C. V., Hermans P. E., Wiesner R. H., Ludwig J., Smith T. F., Rakela J., Krom R. A. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis. 1989 Nov;160(5):752–758. doi: 10.1093/infdis/160.5.752. [DOI] [PubMed] [Google Scholar]
  15. Paya C. V., Holley K. E., Wiesner R. H., Balasubramaniam K., Smith T. F., Espy M. J., Ludwig J., Batts K. P., Hermans P. E., Krom R. A. Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology. 1990 Jul;12(1):119–126. doi: 10.1002/hep.1840120119. [DOI] [PubMed] [Google Scholar]
  16. Paya C. V., Smith T. F., Ludwig J., Hermans P. E. Rapid shell vial culture and tissue histology compared with serology for the rapid diagnosis of cytomegalovirus infection in liver transplantation. Mayo Clin Proc. 1989 Jun;64(6):670–675. doi: 10.1016/s0025-6196(12)65346-4. [DOI] [PubMed] [Google Scholar]
  17. Paya C. V., Wiesner R. H., Hermans P. E., Larson-Keller J. J., Ilstrup D. M., Krom R. A., Rettke S., Smith T. F. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol. 1993 Jun;18(2):185–195. doi: 10.1016/s0168-8278(05)80245-4. [DOI] [PubMed] [Google Scholar]
  18. Rabah R., Jaffe R. Early detection of cytomegalovirus in the allograft liver biopsy: a comparison of methods. Pediatr Pathol. 1987;7(5-6):549–556. doi: 10.3109/15513818709161418. [DOI] [PubMed] [Google Scholar]
  19. Rakela J., Wiesner R. H., Taswell H. F., Hermans P. E., Smith T. F., Perkins J. D., Krom R. A. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc. 1987 Feb;19(1 Pt 3):2399–2402. [PubMed] [Google Scholar]
  20. Reller L. B. Granulomatous hepatitis associated with acute cytomegalovirus infection. Lancet. 1973 Jan 6;1(7793):20–22. [PubMed] [Google Scholar]
  21. Rubin R. H. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989 Jun 23;261(24):3607–3609. [PubMed] [Google Scholar]
  22. Singh N., Dummer J. S., Kusne S., Breinig M. K., Armstrong J. A., Makowka L., Starzl T. E., Ho M. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988 Jul;158(1):124–131. doi: 10.1093/infdis/158.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Snover D. C., Hutton S., Balfour H. H., Jr, Bloomer J. R. Cytomegalovirus infection of the liver in transplant recipients. J Clin Gastroenterol. 1987 Dec;9(6):659–665. doi: 10.1097/00004836-198712000-00010. [DOI] [PubMed] [Google Scholar]
  24. Stratta R. J., Shaefer M. S., Markin R. S., Wood R. P., Kennedy E. M., Langnas A. N., Reed E. C., Woods G. L., Donovan J. P., Pillen T. J. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg. 1989 Dec;124(12):1443–1450. doi: 10.1001/archsurg.1989.01410120093018. [DOI] [PubMed] [Google Scholar]
  25. Stratta R. J., Shaeffer M. S., Markin R. S., Wood R. P., Langnas A. N., Reed E. C., Donovan J. P., Woods G. L., Bradshaw K. A., Pillen T. J. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992 May;37(5):673–688. doi: 10.1007/BF01296422. [DOI] [PubMed] [Google Scholar]
  26. Ten Napel C. H., Houthoff H. J., The T. H. Cytomegalovirus hepatitis in normal and immune compromised hosts. Liver. 1984 Jun;4(3):184–194. doi: 10.1111/j.1600-0676.1984.tb00926.x. [DOI] [PubMed] [Google Scholar]
  27. Theise N. D., Conn M., Thung S. N. Localization of cytomegalovirus antigens in liver allografts over time. Hum Pathol. 1993 Jan;24(1):103–108. doi: 10.1016/0046-8177(93)90069-s. [DOI] [PubMed] [Google Scholar]
  28. Toorkey C. B., Carrigan D. R. Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis. 1989 Nov;160(5):741–751. doi: 10.1093/infdis/160.5.741. [DOI] [PubMed] [Google Scholar]
  29. Zweygberg Wirgart B., Landqvist M., Hökeberg I., Eriksson B. M., Olding-Stenkvist E., Grillner L. Early detection of cytomegalovirus in cell culture by a new monoclonal antibody, CCH2. J Virol Methods. 1990 Feb;27(2):211–219. doi: 10.1016/0166-0934(90)90137-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES